Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanna Lei

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|September 27, 2021
Unexpected Favorable Outcome to PD-1 Antibody Plus Lenvatinib in a Patient With Recurrent Intestinal Follicular Dendritic Cell Sarcoma: A Case Report and Literature ReviewYanna Lei, Sha Zhao, Ming Jiang
Frontiers in Cell and Developmental Biology|December 21, 2020
A Highlight of the Mechanisms of Immune Checkpoint Blocker ResistanceQian Huang, Yanna Lei, Xiaoying Li, et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|September 18, 2018
[Anti-inflammatory effects of penehyclidine hydrochloride on acute respiratory distress syndrome in rats]Huixian Xu, Jing Xie, Yanna Lei, et al.
Frontiers in Oncology|March 29, 2021
Progress and Challenges of Predictive Biomarkers for Immune Checkpoint BlockadeYanna Lei, Xiaoying Li, Qian Huang, et al.
Frontiers in Oncology|March 7, 2022
Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular CarcinomaXiufeng Zheng, Xun Liu, Yanna Lei, et al.
Medicine|January 21, 2022
Characteristics and survival outcomes of primary splenic cancers: A SEER population-based studyYanna Lei, Qian Huang, Xiaoying Li, et al.
Frontiers in Immunology|February 13, 2023
gC1qR: A New Target for Cancer ImmunotherapyYanna Lei, Xiaoyu Li, Diyuan Qin, et al.
Frontiers in Pharmacology|July 22, 2022
Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World DataYanna Lei, Xiufeng Zheng, Qian Huang, et al.
Frontiers in Immunology|March 19, 2024
Targeting tumor-infiltrating tregs for improved antitumor responsesDiyuan Qin, Yugu Zhang, Pei Shu, et al.
Cancer Medicine|September 21, 2023
Perspectives for immunotherapy of EBV-associated GLELC: A relatively "hot" tumor microenvironmentYanna Lei, Peng Cao, Xiufeng Zheng, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|September 27, 2021
Unexpected Favorable Outcome to PD-1 Antibody Plus Lenvatinib in a Patient With Recurrent Intestinal Follicular Dendritic Cell Sarcoma: A Case Report and Literature ReviewYanna Lei, Sha Zhao, Ming Jiang
Frontiers in Cell and Developmental Biology|December 21, 2020
A Highlight of the Mechanisms of Immune Checkpoint Blocker ResistanceQian Huang, Yanna Lei, Xiaoying Li, et al.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue|September 18, 2018
[Anti-inflammatory effects of penehyclidine hydrochloride on acute respiratory distress syndrome in rats]Huixian Xu, Jing Xie, Yanna Lei, et al.
Frontiers in Oncology|March 29, 2021
Progress and Challenges of Predictive Biomarkers for Immune Checkpoint BlockadeYanna Lei, Xiaoying Li, Qian Huang, et al.
Frontiers in Oncology|March 7, 2022
Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular CarcinomaXiufeng Zheng, Xun Liu, Yanna Lei, et al.
Medicine|January 21, 2022
Characteristics and survival outcomes of primary splenic cancers: A SEER population-based studyYanna Lei, Qian Huang, Xiaoying Li, et al.
Frontiers in Immunology|February 13, 2023
gC1qR: A New Target for Cancer ImmunotherapyYanna Lei, Xiaoyu Li, Diyuan Qin, et al.
Frontiers in Pharmacology|July 22, 2022
Intrinsic Differences in Immune Checkpoint Inhibitor-Induced Myocarditis: A Retrospective Analysis of Real World DataYanna Lei, Xiufeng Zheng, Qian Huang, et al.
Frontiers in Immunology|March 19, 2024
Targeting tumor-infiltrating tregs for improved antitumor responsesDiyuan Qin, Yugu Zhang, Pei Shu, et al.
Cancer Medicine|September 21, 2023
Perspectives for immunotherapy of EBV-associated GLELC: A relatively "hot" tumor microenvironmentYanna Lei, Peng Cao, Xiufeng Zheng, et al.
Pageof 4